Urinalysis Market To Witness Growth Rapidly Due To Growing Prevalence Of Sedentary Lifestyle Till 2022: Grand View Research, Inc.
Global urinalysis market is expected to reach over USD
2.14 billion by 2022, according to a new report by Grand View Research,
Inc.
Automation
is a key technological advancement affecting the efficiency and accuracy delivered
by the new generation urinalysis devices and hence, the persistent demand for
novel urinalysis instruments and consumables. For instance, the automatic
bench-top and portable biochemical urine analyzers, automated urine sediment
analyzers (Aution Hybrid AU-4050 from Arkray),and automated microscopic urine
analyzers (Sysmex UF-1000i) are the next generation, advanced instruments is
anticipated to foster the urinalysis market growth.
The
introduction of CLIA-waived urine reagent strips such as CLIA-URS-10,
CLIA-URS-10-3PROMO, and CLIA-URS-10-10 provide for an effective screening tool
for rapid testing in urine analysis which are estimated to enhance the usage
rates of urinalysis reagents thus accentuating the market growth over the
forecast period.
The
target population base for urinalysis market is increasing owing to, factors
such as the rising prevalence of target diseases, misdiagnosis, and low
awareness levels pertaining to urine analysis in low-income countries. High
incidences of obesity coupled with hypertension, diabetes, and other chronic
disorders foster the growth of the urinalysis market.
U.S.
urinalysis market, by application, 2012 - 2022 (USD Million)
Browse full
research report on Urinalysis Market: https://www.grandviewresearch.com/industry-analysis/urinalysis-market
Further key
findings from the report suggest:
- Urinary Tract Infections (UTIs)dominated the
application segment in 2014. The foremost factor responsible for its high
share is the rising prevalence of UTIs, especially in females. However,
diabetes is estimated to be the fastest growing application segment with a
CAGR of over 10% during the forecast period owing to a surge in the demand
for automated and user-friendly urinalysis products for long-term diabetes
management.
- Consumables held the largest share with revenue
generation of over USD 1 million in 2014. The increasing usage of test
strips and reagents for urinalysisis one of the major factors that are
attributed to its large market share. However, the instrument segment is
expected to witness the fastest growth with a CAGR of over 7%. Automation
of instruments with improved efficiency and reliability is expected to
govern this segment’s growth.
- The home healthcare segment, on the other hand,
is anticipated to grow at a substantial rate over 7.5%. The availability
of technologically enabled point-of-care urinalysis systems, such as
CLINITEK Status, is a key factor expected to reinforce the market growth.
- North America dominated the overall urinalysis
market with a revenue generation of over USD 540 million in 2014. The
introduction of advanced urine analyzers by key market players in the
U.S., favorable government initiatives ensuring the betterment of
healthcare testing, and the high amount of healthcare spending in this
region are the key factors attributing to the largest market share of this
region.
- Key players of this market include Roche
Diagnostics, Alere, Inc., Siemens Healthcare, Bio-Rad, ARKRAY, Inc.,
Mindray, and Sysmex.
- Market participants are constantly engaged in
the introduction of novel diagnostic products in an attempt to ensure
their sustainability and increase the penetration of their product
portfolio. For instance, in June 2014, Roche launched a fully automated urine
testing analyzer named Cobas 6500 with an objective to enhance staff
safety and increase the result reliability.
Browse more
reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the global urinalysis market on the
basis of product, application, end-use, and region:
Global
Urinalysis Product Outlook (Revenue, USD Million, 2015 - 2022)
- Instruments
- Biochemical
urine analyzers
- Automated
biochemical analyzers
- Semi-automated
biochemical analyzers
- Automated
urine sediment analyzers
- Microscopic
urine analyzers
- Flow-cytometric
urine analyzers
- Consumables
- Dipsticks
- Reagents
- Disposables
Global
Urinalysis Application Outlook (Revenue, USD Million, 2015 - 2022)
- UTIs
- Diabetes
- Kidney
Disease
- Hypertension
- Liver
disease
- Others
Global
Urinalysis End-use Outlook (Revenue, USD Million, 2015 - 2022)
- Hospitals
- Clinical
Laboratories
- Home
healthcare
- Research
and academics
- Others
Urinalysis
Regional Outlook (Revenue, USD Million, 2015 - 2022)
- North
America
- U.S.
- Canada
- Europe
- U.K
- Germany
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- MEA
- South
Africa
Access
Press Release By Grand View Research: https://www.grandviewresearch.com/press-release/global-urinalysis-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment